The Asia-Pacific pen needle market is anticipated to grow at a CAGR of 9.4% during the forecast period. The rapidly increasing prevalence of diabetes is creating a substantial scope for the growth of the pen needle industry in the Asia-Pacific region over the forecast period. Highly populated countries such as India and China are experiencing a significant increase in the cases of diabetes...

The Asia-Pacific pen needle market is anticipated to grow at a CAGR of 9.4% during the forecast period. The major factor influencing the growth of the market across Asia-Pacific includes the increased prevalence of diabetes. The International Diabetes Federation (IDF) divided Asia-Pacific into South-East Asia and the Western Pacific. Asia-Pacific Pen Needle Market research report allows making...

The Asia-Pacific pen needle market is anticipated to grow at a CAGR of 9.4% during the forecast period. The rapidly increasing prevalence of diabetes is creating a substantial scope for the growth of the pen needle industry in the Asia-Pacific region over the forecast period. Highly populated countries such as India and China are experiencing a significant increase in the cases of diabetes...

Market Highlights: The Diabetic lancing device market size is expected to reach USD 1,642.01 Million by 2030 at 13.2% CAGR during the forecast period 2022-2030 Diabetes mellitus is a group of metabolic disorders which arises due to high blood glucose levels. This condition arises due to the absence of insulin, a hormone responsible for regulating blood sugar. Nearly 415 million people...

Insulin delivery devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 6.20% in the above-mentioned forecast period.   Market Analysis and Insights of Insulin Delivery Devices Market Insulin is basically a vital part of the treatment plan for all patients suffering from Type 1 and Type 2...

The European pen needle market is anticipated to grow at a CAGR of 7.7% during the forecast period. The lucrative growth of the region is attributed to the presence of key players such as B. Braun Melsungen AG, Novo Nordisk A/S, Smiths Group Plc., and Vygon SA, which are pioneers in innovation, design, and manufacture of pen needles. European Pen Needle Market research report allows making...

The European pen needle market is anticipated to grow at a CAGR of 7.7% during the forecast period. The growth of the market is attributed to the easy availability of such devices owing to the strong presence of various global companies such as B. Braun Melsungen AG, Novo Nordisk A/S, Smiths Group Plc. and Vygon SA.    Additionally, the significant increase in the number of diabetes...

The European pen needle market is anticipated to grow at a CAGR of 7.7% during the forecast period. The growth of the market is attributed to the easy availability of such devices owing to the strong presence of various global companies such as B. Braun Melsungen AG, Novo Nordisk A/S, Smiths Group Plc. and Vygon SA.    Additionally, the significant increase in the number of diabetes...

Data Bridge Market Research analyses that the human insulin drugs and delivery devices market was valued at USD 42.85 billion in 2021 and is expected to reach USD 80.79 billion by 2029, registering a CAGR of 8.25% during the forecast period of 2022 to 2029. Market Definition Insulin is a protein hormone that assists people whose bodies cannot make enough insulin control their blood sugar...

The Indian pen needle market is anticipated to grow at a CAGR of 10.1% during the forecast period. An increased number of people suffering from diabetes in the country increases the demand for pen needles, which is a major factor fuelling the growth of the market. Indian Pen Needle Market research report allows making important decision making essential for business growth. It helps key...